CXCR4 and dilated cardiomyopathy: In mice with experimental dilated cardiomyopathy we showed that administration of AMD3100, a highly selective CXCR4 antagonist, was associated with a marked reduction in perivascular and interstitial fibrosis, supported by a reduction in the expression of collagen I mRNA.